According to a recent study conducted at thirteen sites across the world, early HIV treatment could reduce infection risk by as much as 96%.
The study has been conducted since 2008 and it involved more than 1763 couples in Africa, Asia and in North and South America. A total of 97 couples in Johannesburg participated in the trials. Wits Researcher Doctor Guy de Bruyn says their findings suggest that HIV-infected patients will benefit from taking anti-retrovirals (ARVs) when their CD4 levels are between 350 and 550, because it will protect their HIV negative partners and improve the patient's health.
"The most important finding is that early initiation of anti-retroviral therapy reduces transmission of HIV from the infected partner to the uninfected partner by 96%. That was found by comparing the number of infections that occurred between the two groups; the group that received early therapy and the group that received therapy according to standard guidelines," says de Bruyn.